🇺🇸 FDA
Patent

US 8222421

Certain substituted ureas, as modulators of kinase activity

granted A61PA61P17/06A61P19/02

Quick answer

US patent 8222421 (Certain substituted ureas, as modulators of kinase activity) held by GILEAD CONNECTICUT, INC. expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GILEAD CONNECTICUT, INC.
Grant date
Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61P, A61P17/06, A61P19/02, A61P27/02, A61P29/00